Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset

Rubén Queiro1, Daniel Seoane-Mato2, Ana Laiz3

  • 1Rheumatology Service and the Principality of Asturias Institute for Health Research (ISPA), Faculty of Medicine, Universidad de Oviedo, Avenida de Roma s/n, Asturias, Oviedo 33011, Spain.

Abstract